期刊文献+

浊点萃取-高效液相色谱法同时测定药片与尿样中异烟肼、利福平和吡嗪酰胺 被引量:4

Simultaneous Determination of Isoniazid,Rifampicin and Pyrazinamide in Pharmaceuticals and Human Urine by Cloud Point Extraction High Performance Liquid Chromatography
下载PDF
导出
摘要 建立了以聚乙二醇(PEG)6000为萃取剂的浊点萃取(CPE)-反相高效液相色谱同时测定异烟肼、利福平和吡嗪酰胺的方法,由于异烟肼不易被浊点萃取方法富集,使异烟肼与对氯苯甲醛在酸性条件下反应衍生为异烟肼腙,异烟肼腙在液相色谱上的信号与异烟肼浓度存在着线性关系。在优化的CPE条件下,采用梯度洗脱的方式,用紫外检测器在310 nm波长下,异烟肼、吡嗪酰胺和利福平的保留时间分别为14.5、34.4和38.1 min,定量范围分别是0.01~10 mg/L、0.08~25 mg/L和0.05~20 mg/L。线性相关系数r>0.99。3种药的平均回收率范围为91.50%~98.75%,精密度(RSD)为0.22%~1.54%。异烟肼、利福平和吡嗪酰胺的检出限分别为4×10-3、2×10-2和3×10-2mg/L。本法用于药片和尿样中3种药物的检测,结果满意。 Isoniazid(IN) can not be sufficiently extracted by the cloud point extraction(CPE) of polylethyle- neglyeol(PEG) 6000, and reacts with para-chlorobenzaldehyde to form a derivative(para-chlorobenzaldehyde- isonicotiny- hydrazone, CIH). It was proven that there was linear relationship between the signal of CIH and the concentration of IN. A cloud point extraction system of polylethyleneglycol 6000(NH4)2SO4 coupled with high performance liquid chromatography was developed for the separation and the simultaneous determination of isoniazid(IN) , pyrazinamide(PZ) and rifampicin(RF). Under the optimum conditions, the analytes were eluted with a gradient mode and detected with a UV-deteetor at 310 nm, the retention time of isoniazid, pyraz- inamide and rifampiein was 14.5, 34.4 and 38.1 rain, respectively, the linear calibration curves in the range of 0.01 -10 mg/L for isoniazid and 0.05 -20 mg/L for pyrazinamide and 0.08 -25 mg/L for rifampicin, respectively(r 〉 0.99). Average recoveries of three drugs ranged from 91.5% to 98.6% with relative stand- ard deviations from0.2% to 1.5%. The limits of detection of IN, PZ and RF was 4 ×10-3, 2 ×10-2 and 3 ×10-2 mg/L, respectively. The CPE-HPLC-UV method had been applied to the determination of IN, PZ and RF in pharmaceuticals and in urine samples.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2009年第6期845-849,共5页 Chinese Journal of Analytical Chemistry
关键词 浊点萃取 液相色谱 异烟肼 利福平 吡嗪酰胺 Cloud point extraction, high performance liquid chromatography, isoniazid, rifampicin, pyrazinamide
  • 相关文献

参考文献18

  • 1Safavi A, Karimi M A, Hormozi N M R, Kamali R, Saghir N. Spectrochim. Acta A, 2004, 60:765 -769.
  • 2Lapa A S, Lima L F C, Santos L M. Anal. Chim. Acta, 2000, 419:17 -23.
  • 3Shrutidevi A, Inderiit S, Kanwal J K, Shantaram R B, Chaman L K, Ramesh P. Int. J. Pharm. , 2004, 276:41 -49.
  • 4Calleri E, Lorenzi E D, Furlanetto S, Massolini G, Caccialanza G. J. Pharm. Biomed. Anal. , 2002, 29:1089 -1096.
  • 5Unsalan S, Sancar M, Bekce B, Clark P M, Karagoz T, Izzettin F V, Rollas S. Chromatographia, 2005, 61:595 -598.
  • 6Goicoechea H C, Olivieri A C. J. Pharm. Biomed. Anal. , 1999, 20:681-686.
  • 7Nguyen D T T, Guillarme D, Rudaz S, Veutheyl J L. J. Sep. Sci. , 2008, 31 : 1050 - 1056.
  • 8Argekar A P, Kunjir S S, Purandare K S. J. Pharm. Biomed. Anal. , 1999, 14:1645 - 1650.
  • 9Song S H, Jun S H, Park K U, Yoon Y, Lee J H, Kim J H, Song J. Rapid Commun. Mass Spectrom. , 2007, 21: 1331 - 1338.
  • 10Ng K Y, Zhou H Y, Zhang Y L, Hybertson B, Randolph T, Christians U. J. Chromatogr. B, 2007, 847(2) : 188- 198.

二级参考文献133

共引文献90

同被引文献1971

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部